Miller Fisher Syndrome Presenting After a Second Dose of Pfizer-BioNTech Vaccination in a Patient With Resolved COVID-19: A Case Report

J Clin Neuromuscul Dis. 2021 Dec 1;23(2):113-115. doi: 10.1097/CND.0000000000000376.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adverse Drug Reaction Reporting Systems
  • Aged
  • BNT162 Vaccine / administration & dosage
  • BNT162 Vaccine / adverse effects*
  • COVID-19* / prevention & control
  • COVID-19* / therapy
  • Humans
  • Male
  • Miller Fisher Syndrome* / diagnosis
  • Miller Fisher Syndrome* / drug therapy
  • SARS-CoV-2
  • Vaccination

Substances

  • BNT162 Vaccine